Two monitoring methods of oral anticoagulant therapy in patients with mechanical heart valve prothesis: a meta-analysis
- 590 Downloads
Oral anticoagulant therapy (OAT) with warfarin has become the standard therapy for the patients with mechanical heart valve prothesis. The monitoring method of self-monitoring or self-management was promising to optimize the use of warfarin, but most of previous studies have included patients with various indications of OAT, which made it difficult to extrapolate the results to the specific patient population with mechanical heart valve prostheses. This study was intended to evaluate the new and traditional monitoring methods in patients with mechanical heart valve prostheses. Relevant literature finished before Dec. 2010 were searched through a number of digital databases. And then they were pooled by RevMan 4.2 and R 2.13.0 in three fields: rate within the target range, test frequency and occurrence rate of poor events. Five randomized control trials with a total of 2,219 patients were identified. Pooled estimates showed reductions in thromboembolic events (OR 0.52, 95% CI 0.35–0.77; P = 0.0012) and all-cause mortality (OR 0.50, 95% CI 0.29–0.86; P = 0.0115). No difference was noted in major and minor haemorrhage. All trials reported improvements in the mean proportion of international normalized ratios in range. Self-monitoring and self-management can improve the quality of OAT in the patients with mechanical heart valve prostheses. The patients spend more time within the therapeutic range resulting in decreases in thromboembolic events and mortality, with no increase in haemorrhage. However, self-monitoring and self-management was not feasible for all patients, and require identification and education of suitable candidates. The success of self-monitoring and self-management method depends on consistent, regular, and frequent testing.
KeywordsAnticoagulants Vitamin K Coumarins Self-care Meta analysis Heart valve prosthesis implantation
We thank Yana Wang, and Xiaohong Ni, for their assistance with article writing, Mei Jiang and Yong Huang for assistance with statistical analysis, and Jing Fan for secretarial assistance.
Conflict of interest
- 1.Altman LK (2008) 4 winners of Lasker medical prize. New York Times. http://www.nytimes.com/2007/09/16/health/16lasker.htm. Accessed 22 Jan 2008
- 3.Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD et al (2008) 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118(15):e523–e661PubMedCrossRefGoogle Scholar
- 11.Andersen PV, Aagaard J (2000) Low-dose warfarin in patients with carbomedics heart valve prostheses. Asian Cardiovasc Thorac Ann 8(1):11–14Google Scholar
- 19.Ansell J, Jacobson A, Levy J, Völler H, Hasenkam JM (2005) International Self-Monitoring Association for Oral Anticoagulation. Guidelines for implementation of patient selftesting and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation. Int J Cardiol 99(1):37–45PubMedCrossRefGoogle Scholar
- 23.Garcia-Alamino JM, Ward AM, Alonso-Coello P, Perera R, Bankhead C, Fitzmaurice D et al (2010) Self-monitoring and self-management of oral anticoagulation. Cochrane Database Syst Rev (4):CD003839Google Scholar